UN reports large-scale captagon production disrupted in post-Assad Syria

Large-scale production of the illicit amphetamine captagon in Syria has been significantly disrupted following the ouster of the Assad regime, according to a new research brief from the UN Office on Drugs and Crime (UNODC). Preliminary findings indicate Syrian authorities have dismantled 15 industrial-scale labs and 13 storage sites since December 2024.

Record Regional Seizures and Market Impact

The disruption coincides with unprecedented regional interdiction efforts. The UNODC has verified the seizure of at least 177 million captagon tablets (approximately 30 tons) across the Arab region since December 2024. "Countries are collaborating, sharing intelligence and running joint operations, leading to record seizures in 2025," said UNODC Director for Operations Bo Mathiasen. Gulf countries remain the primary destination, but signs of market shortages suggest increased enforcement is impacting supply.

Ongoing Risks and Potential Shift to Other Drugs

Despite the progress, the UN agency cautions that risks remain. It notes that captagon production previously observed outside Syria likely continues elsewhere in the Middle East, and large pre-existing stockpiles could fuel trafficking networks for years. The brief also warns that criminal networks may pivot toward methamphetamine and other synthetic drugs, urging strengthened prevention and treatment measures alongside continued law enforcement cooperation.